(+)-artemisinin decreases activity ISO RGD:1349200 6480464 artemisinin results in decreased activity of GSTA1 protein CTD PMID:11807801 1,2-Dibromo-3-chloropropane affects metabolic processing ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of 1, 2-dibromo-3-chloropropane CTD PMID:8242859 1,2-Dibromo-3-chloropropane increases response to substance ISO RGD:1349200 6480464 GSTA1 protein results in increased susceptibility to 1, 2-dibromo-3-chloropropane CTD PMID:8242859 1,2-dichloroethane multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of and results in increased activity of and results in increased susceptibility to ethylene dichloride CTD PMID:11673082 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of GSTA1 mRNA CTD PMID:32387197 1-chloro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrochlorobenzene results in increased expression of GSTA1 protein CTD PMID:9794801 1-chloro-2,4-dinitrobenzene increases metabolic processing ISO RGD:1349200 6480464 GSTA1 protein results in increased metabolism of Dinitrochlorobenzene CTD PMID:3138230 1-chloro-2,4-dinitrobenzene multiple interactions ISO RGD:1349200 6480464 [GSTA1 protein binds to GSTA1 protein] which affects the metabolism of Dinitrochlorobenzene more ... CTD PMID:11851347 more ... 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of GSTA1 mRNA CTD PMID:20551477 1-naphthyl isothiocyanate multiple interactions ISO RGD:1349200 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of GSTA1 mRNA CTD PMID:27344345 13-oxo-9,11-octadecadienoic acid affects metabolic processing ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of 13-oxo-9, 11-octadecadienoic acid CTD PMID:12031293 17-beta-Estradiol-3,17-beta-sulfate multiple interactions ISO RGD:1349200 6480464 estradiol 3, 17-disulfate binds to and results in decreased activity of GSTA1 protein CTD PMID:12206662 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of GSTA1 mRNA CTD PMID:12655037 , PMID:15834898 17beta-estradiol decreases expression ISO RGD:1349200 6480464 Estradiol results in decreased expression of GSTA1 mRNA CTD PMID:23019147 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1349200 6480464 [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of GSTA1 mRNA CTD PMID:29162470 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GSTA1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1349200 6480464 Tetrachlorodibenzodioxin results in decreased expression of GSTA1 mRNA CTD PMID:20106945 more ... 2-Acetoxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of and results in decreased activity of 2-(acetoxyamino)-1-methyl-6-phenylimidazo(4, 5-b)pyridine CTD PMID:11535243 more ... 2-Acetoxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases response to substance ISO RGD:1349200 6480464 GSTA1 protein polymorphism results in increased susceptibility to 2-(acetoxyamino)-1-methyl-6-phenylimidazo(4, 5-b)pyridine CTD PMID:11535243 2-allylphenol decreases activity ISO RGD:1349200 6480464 2-allylphenol results in decreased activity of GSTA1 protein CTD PMID:8620581 2-hexenal increases expression EXP 6480464 2-hexenal results in increased expression of GSTA1 mRNA CTD PMID:9799558 2-phenylpropanal multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of [hydratropic aldehyde co-treated with Glutathione] CTD PMID:11368548 2-phenylpropanal decreases activity ISO RGD:1349200 6480464 GSTA1 protein results in decreased activity of hydratropic aldehyde CTD PMID:11368548 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine decreases expression ISO RGD:1349200 6480464 3 more ... CTD PMID:23810796 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of GSTA1 mRNA CTD PMID:28522335 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of GSTA1 protein CTD PMID:34915118 3-methylpyridine decreases expression ISO RGD:1349200 6480464 3-methylpyridine results in decreased expression of GSTA1 protein CTD PMID:7986210 4-hydroxynon-2-enal decreases response to substance ISO RGD:1349200 6480464 GSTA1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal CTD PMID:15829614 4-hydroxynon-2-enal multiple interactions EXP 6480464 [GSTA1 protein binds to GSTA3 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog CTD PMID:11256969 4-hydroxynon-2-enal affects metabolic processing EXP 6480464 GSTA1 protein affects the metabolism of 4-hydroxy-2-nonenal analog CTD PMID:11256969 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of GSTA1 mRNA CTD PMID:9799558 4-nitrophenol increases expression EXP 6480464 4-nitrophenol results in increased expression of GSTA1 mRNA CTD PMID:27172127 4-Propylphenol decreases activity ISO RGD:1349200 6480464 4-propylphenol results in decreased activity of GSTA1 protein CTD PMID:8620581 5-Hydroxythalidomide affects binding ISO RGD:1349200 6480464 5-hydroxythalidomide binds to GSTA1 protein CTD PMID:27464947 7,12-dimethyltetraphene decreases activity EXP 6480464 9 more ... CTD PMID:30027798 7,12-dimethyltetraphene multiple interactions EXP 6480464 brucine inhibits the reaction [9 more ... CTD PMID:30027798 8-anilinonaphthalene-1-sulfonic acid affects binding ISO RGD:1349200 6480464 1-anilino-8-naphthalenesulfonate binds to GSTA1 protein CTD PMID:14690442 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of GSTA1 mRNA CTD PMID:31881176 acrolein increases expression EXP 6480464 Acrolein results in increased expression of GSTA1 mRNA CTD PMID:9799558 actinomycin D multiple interactions ISO RGD:1349200 6480464 Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of GSTA1 mRNA] CTD PMID:28483492 aflatoxin B1 affects binding ISO RGD:1349200 6480464 Aflatoxin B1 binds to GSTA1 protein CTD PMID:9826190 aflatoxin B1 decreases expression ISO RGD:1349200 6480464 Aflatoxin B1 results in decreased expression of GSTA1 mRNA CTD PMID:21632981 , PMID:21641981 aflatoxin B1 affects expression ISO RGD:1349200 6480464 Aflatoxin B1 affects the expression of GSTA1 protein CTD PMID:20106945 alpha-linolenic acid increases expression ISO RGD:1349200 6480464 alpha-Linolenic Acid results in increased expression of GSTA1 mRNA CTD PMID:28555106 alpha-linolenic acid multiple interactions ISO RGD:1349200 6480464 NFE2L2 protein promotes the reaction [alpha-Linolenic Acid results in increased expression of GSTA1 mRNA] CTD PMID:28555106 alpha-methyl-L-dopa decreases activity ISO RGD:1349200 6480464 Methyldopa analog results in decreased activity of GSTA1 protein CTD PMID:8131222 alternariol affects localization ISO RGD:1349200 6480464 alternariol affects the localization of GSTA1 mRNA CTD PMID:23154127 aluminium oxide increases expression EXP 6480464 Aluminum Oxide results in increased expression of GSTA1 mRNA CTD PMID:35403826 aluminium oxide multiple interactions EXP 6480464 sesamol inhibits the reaction [Aluminum Oxide results in increased expression of GSTA1 mRNA] CTD PMID:35403826 amitrole multiple interactions EXP 6480464 Amitrole inhibits the reaction [cobaltous chloride results in increased expression of GSTA1 mRNA], Amitrole inhibits the reaction [cobaltous chloride results in increased expression of GSTA1 protein] CTD PMID:25820916 androst-4-ene-3,17-dione increases chemical synthesis ISO RGD:1349200 6480464 GSTA1 protein results in increased chemical synthesis of Androstenedione CTD PMID:23650189 androst-5-ene-3,17-dione affects metabolic processing ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of 5-androstene-3, 17-dione CTD PMID:11152686 androst-5-ene-3,17-dione increases metabolic processing ISO RGD:1349200 6480464 GSTA1 protein results in increased metabolism of 5-androstene-3, 17-dione CTD PMID:16280386 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1349200 6480464 pyrazolanthrone inhibits the reaction [Acetaminophen results in decreased expression of GSTA1 mRNA], pyrazolanthrone inhibits the reaction [Acetaminophen results in decreased expression of GSTA1 protein] CTD PMID:33959992 Aroclor 1254 increases expression ISO RGD:1349200 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of GSTA1 mRNA CTD PMID:17851650 arotinoid acid multiple interactions ISO RGD:1349200 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsenous acid multiple interactions ISO RGD:1349200 6480464 Atrazine promotes the reaction [Arsenic Trioxide results in increased expression of GSTA1 mRNA] CTD PMID:11678611 arsenous acid increases expression ISO RGD:1349200 6480464 Arsenic Trioxide results in increased expression of GSTA1 mRNA CTD PMID:11678611 , PMID:20458559 atazanavir sulfate decreases expression ISO RGD:1349200 6480464 Atazanavir Sulfate results in decreased expression of GSTA1 mRNA CTD PMID:32152650 atazanavir sulfate multiple interactions ISO RGD:1349200 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTA1 mRNA CTD PMID:32152650 atrazine multiple interactions ISO RGD:1349200 6480464 Atrazine promotes the reaction [arsenic trioxide results in increased expression of GSTA1 mRNA] CTD PMID:11678611 atrazine increases expression EXP 6480464 Atrazine results in increased expression of GSTA1 mRNA CTD PMID:36841081 Azaspiracid decreases expression ISO RGD:1349200 6480464 azaspiracid results in decreased expression of GSTA1 mRNA CTD PMID:28939011 azathioprine affects metabolic processing ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of Azathioprine CTD PMID:18155239 Bardoxolone methyl decreases expression ISO RGD:1349200 6480464 bardoxolone methyl results in decreased expression of GSTA1 mRNA CTD PMID:34480604 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene metabolite results in increased expression of GSTA1 mRNA, Benzo(a)pyrene results in increased expression of GSTA1 mRNA CTD PMID:11008122 benzo[a]pyrene increases methylation ISO RGD:1349200 6480464 Benzo(a)pyrene results in increased methylation of GSTA1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1349200 6480464 Benzo(a)pyrene affects the methylation of GSTA1 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1349200 6480464 Benzo(a)pyrene results in increased expression of GSTA1 mRNA CTD PMID:31255691 , PMID:32890658 benzo[a]pyrene decreases expression ISO RGD:1349200 6480464 Benzo(a)pyrene results in decreased expression of GSTA1 mRNA CTD PMID:22316170 more ... benzo[a]pyrene diol epoxide I multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of and results in decreased activity of [7 more ... CTD PMID:11849043 Benzo[a]pyrene-7,8-diol increases expression EXP 6480464 benzo(a)pyrene 7, 8-dihydrodiol results in increased expression of GSTA1 mRNA CTD PMID:11008122 benzoic acid increases activity ISO RGD:1349200 6480464 Benzoic Acid results in increased activity of GSTA1 protein mutant form CTD PMID:10329179 beta-naphthoflavone decreases expression ISO RGD:1349200 6480464 beta-Naphthoflavone results in decreased expression of GSTA1 mRNA CTD PMID:25218365 beta-naphthoflavone increases expression ISO RGD:1349200 6480464 beta-Naphthoflavone results in increased expression of GSTA1 mRNA CTD PMID:33035518 beta-naphthoflavone multiple interactions ISO RGD:1349200 6480464 beta-Naphthoflavone promotes the reaction [AHR protein binds to GSTA1 promoter], beta-Naphthoflavone results in increased expression of and results in increased activity of GSTA1 protein CTD PMID:33035518 bilirubin IXalpha increases expression ISO RGD:1349200 6480464 Bilirubin results in increased expression of GSTA1 mRNA CTD PMID:15382119 bilirubin IXalpha multiple interactions ISO RGD:1349200 6480464 IL1B protein inhibits the reaction [Bilirubin results in increased expression of GSTA1 mRNA] CTD PMID:15382119 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1349200 6480464 Diethylhexyl Phthalate results in increased expression of GSTA1 mRNA CTD PMID:28412506 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GSTA1 mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GSTA1 mRNA CTD PMID:34947998 bisphenol A multiple interactions ISO RGD:1349200 6480464 [NR1I2 gene results in increased susceptibility to bisphenol A] which results in increased expression of GSTA1 mRNA CTD PMID:29425287 bisphenol A affects expression ISO RGD:1349200 6480464 bisphenol A affects the expression of GSTA1 mRNA CTD PMID:30903817 bromosulfophthalein multiple interactions ISO RGD:1349200 6480464 Sulfobromophthalein binds to and affects the folding of and affects the activity of GSTA1 protein CTD PMID:9826190 bromosulfophthalein multiple interactions EXP 6480464 Sulfobromophthalein binds to [GSTA1 protein co-treated with GSTA1 protein], Sulfobromophthalein binds to [GSTA3 protein co-treated with GSTA1 protein] CTD PMID:3783048 bromosulfophthalein affects binding ISO RGD:1349200 6480464 Sulfobromophthalein binds to GSTA1 protein CTD PMID:15147239 brucine multiple interactions EXP 6480464 brucine inhibits the reaction [9 more ... CTD PMID:30027798 bucladesine multiple interactions ISO RGD:1349200 6480464 KT 5720 inhibits the reaction [Bucladesine results in increased expression of GSTA1 mRNA] CTD PMID:26049102 bucladesine increases expression ISO RGD:1349200 6480464 Bucladesine results in increased expression of GSTA1 mRNA CTD PMID:26049102 busulfan affects response to substance ISO RGD:1349200 6480464 GSTA1 polymorphism affects the susceptibility to Busulfan CTD PMID:21441958 busulfan affects metabolic processing ISO RGD:1349200 6480464 GSTA1 gene polymorphism affects the metabolism of Busulfan, GSTA1 protein affects the metabolism of Busulfan CTD PMID:10570028 more ... busulfan affects abundance ISO RGD:1349200 6480464 GSTA1 gene polymorphism affects the abundance of Busulfan CTD PMID:20672371 busulfan decreases response to substance ISO RGD:1349200 6480464 GSTA1 protein results in decreased susceptibility to Busulfan CTD PMID:12429583 busulfan multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of [Busulfan co-treated with Glutathione] CTD PMID:10437668 butane-2,3-dione increases expression ISO RGD:1349200 6480464 Diacetyl results in increased expression of GSTA1 mRNA CTD PMID:31381966 cadmium atom multiple interactions ISO RGD:1349200 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GSTA1 mRNA CTD PMID:35301059 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GSTA1 mRNA CTD PMID:9152014 cadmium dichloride multiple interactions ISO RGD:1349200 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GSTA1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of GSTA1 mRNA], Buthionine Sulfoximine promotes the reaction [Cadmium Chloride results in increased expression of GSTA1 mRNA] CTD PMID:9152014 carbamazepine increases expression ISO RGD:1349200 6480464 Carbamazepine results in increased expression of GSTA1 mRNA CTD PMID:17112801 chenodeoxycholic acid multiple interactions ISO RGD:1349200 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTA1 mRNA more ... CTD PMID:32152650 , PMID:33819548 CHIR 99021 multiple interactions ISO RGD:1349200 6480464 [4-(2-(5 more ... CTD PMID:34480604 chlorambucil decreases activity ISO RGD:1349200 6480464 Chlorambucil analog results in decreased activity of GSTA1 protein CTD PMID:11115505 chlorambucil decreases response to substance ISO RGD:1349200 6480464 GSTA1 protein results in decreased susceptibility to Chlorambucil CTD PMID:11115505 , PMID:14569069 chlorambucil multiple interactions ISO RGD:1349200 6480464 ABCC2 protein promotes the reaction [GSTA1 protein results in decreased susceptibility to Chlorambucil], GSTA1 protein affects the metabolism of [Chlorambucil co-treated with Glutathione] CTD PMID:11115505 , PMID:14569069 chlorpromazine multiple interactions ISO RGD:1349200 6480464 [Chlorpromazine co-treated with Cholic Acids] affects the expression of GSTA1 mRNA CTD PMID:27344345 chlorpyrifos increases expression ISO RGD:1349200 6480464 Chlorpyrifos results in increased expression of GSTA1 mRNA, Chlorpyrifos results in increased expression of GSTA1 protein CTD PMID:21907274 cholic acid multiple interactions EXP 6480464 Cholic Acid binds to [GSTA1 protein co-treated with GSTA1 protein] more ... CTD PMID:3783048 ciprofibrate decreases expression EXP 6480464 ciprofibrate results in decreased expression of GSTA1 mRNA CTD PMID:7676460 cisplatin multiple interactions ISO RGD:1349200 6480464 [Cisplatin co-treated with panobinostat] affects the expression of GSTA1 mRNA CTD PMID:21791302 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of GSTA1 mRNA, Cisplatin results in decreased expression of GSTA1 protein CTD PMID:1394205 cisplatin decreases response to substance ISO RGD:1349200 6480464 GSTA1 results in decreased susceptibility to Cisplatin CTD PMID:21150160 clozapine decreases activity ISO RGD:1349200 6480464 GSTA1 protein results in decreased activity of Clozapine CTD PMID:20849150 clozapine increases glutathionylation ISO RGD:1349200 6480464 GSTA1 protein results in increased glutathionylation of Clozapine CTD PMID:20849150 cobalt atom increases expression ISO RGD:1349200 6480464 Cobalt results in increased expression of GSTA1 mRNA CTD PMID:14971665 cobalt dichloride multiple interactions EXP 6480464 Amitrole inhibits the reaction [cobaltous chloride results in increased expression of GSTA1 mRNA], Amitrole inhibits the reaction [cobaltous chloride results in increased expression of GSTA1 protein] CTD PMID:25820916 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of GSTA1 mRNA, cobaltous chloride results in increased expression of GSTA1 protein CTD PMID:25820916 copper(II) sulfate decreases expression ISO RGD:1349200 6480464 Copper Sulfate results in decreased expression of GSTA1 mRNA CTD PMID:19549813 cortisol increases expression ISO RGD:1349200 6480464 Hydrocortisone results in increased expression of GSTA1 mRNA CTD PMID:11297599 cortisol multiple interactions ISO RGD:1349200 6480464 [4-(2-(5 more ... CTD PMID:11297599 , PMID:34480604 cumene hydroperoxide increases metabolic processing ISO RGD:1349200 6480464 GSTA1 protein results in increased metabolism of cumene hydroperoxide CTD PMID:1985777 cyclophosphamide multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of [Cyclophosphamide metabolite co-treated with Glutathione] CTD PMID:12516103 cyclosporin A multiple interactions ISO RGD:1349200 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of GSTA1 mRNA, [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTA1 mRNA CTD PMID:27344345 , PMID:32152650 cyclosporin A decreases expression ISO RGD:1349200 6480464 Cyclosporine results in decreased expression of GSTA1 mRNA CTD PMID:20106945 more ... DDT increases expression EXP 6480464 DDT results in increased expression of GSTA1 mRNA CTD PMID:30207508 deoxycholic acid multiple interactions ISO RGD:1349200 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTA1 mRNA more ... CTD PMID:32152650 , PMID:33819548 dexamethasone multiple interactions ISO RGD:1349200 6480464 Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of GSTA1 mRNA], Dexamethasone promotes the reaction [NR3C1 protein binds to GSTA1 promoter] CTD PMID:28483492 dexamethasone increases expression ISO RGD:1349200 6480464 Dexamethasone results in increased expression of GSTA1 mRNA, Dexamethasone results in increased expression of GSTA1 protein CTD PMID:28483492 diarsenic trioxide multiple interactions ISO RGD:1349200 6480464 Atrazine promotes the reaction [Arsenic Trioxide results in increased expression of GSTA1 mRNA] CTD PMID:11678611 diarsenic trioxide increases expression ISO RGD:1349200 6480464 Arsenic Trioxide results in increased expression of GSTA1 mRNA CTD PMID:11678611 , PMID:20458559 dibenz[a,h]anthracene multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of and results in decreased susceptibility to 1 more ... CTD PMID:11673082 dibenzo[a,l]pyrene multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of and results in decreased activity of [dibenzo(a more ... CTD PMID:11849043 , PMID:12067250 dibenzo[a,l]pyrene decreases expression ISO RGD:1349200 6480464 dibenzo(a, l)pyrene results in decreased expression of GSTA1 mRNA CTD PMID:31255691 dibenzo[a,l]pyrene increases expression ISO RGD:1349200 6480464 dibenzo(a, l)pyrene results in increased expression of GSTA1 mRNA CTD PMID:32890658 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of GSTA1 mRNA CTD PMID:17379624 diclofenac decreases activity ISO RGD:1349200 6480464 Diclofenac results in decreased activity of GSTA1 protein CTD PMID:27183920 dicrotophos decreases expression ISO RGD:1349200 6480464 dicrotophos results in decreased expression of GSTA1 mRNA CTD PMID:28302478 diethyl maleate affects expression ISO RGD:1349200 6480464 diethyl maleate affects the expression of GSTA1 mRNA CTD PMID:34480604 dimethyl sulfoxide multiple interactions EXP 6480464 Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in decreased expression of GSTA1 protein] CTD PMID:12370186 dinophysistoxin 1 decreases expression ISO RGD:1349200 6480464 dinophysistoxin 1 results in decreased expression of GSTA1 mRNA CTD PMID:28939011 dioxygen decreases expression ISO RGD:1349200 6480464 Oxygen deficiency results in decreased expression of GSTA1 mRNA CTD PMID:19695866 diquat decreases expression EXP 6480464 Diquat results in decreased expression of GSTA1 mRNA CTD PMID:7676460 dopamine decreases activity ISO RGD:1349200 6480464 Dopamine analog results in decreased activity of GSTA1 protein CTD PMID:8131222 doxorubicin multiple interactions ISO RGD:1349200 6480464 GSTA1 protein inhibits the reaction [Doxorubicin results in decreased abundance of Glutathione] more ... CTD PMID:16890185 doxorubicin increases secretion EXP 6480464 Doxorubicin results in increased secretion of GSTA1 protein CTD PMID:28885000 doxorubicin multiple interactions EXP 6480464 Metformin inhibits the reaction [Doxorubicin results in increased expression of GSTA1 mRNA] CTD PMID:22666520 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of GSTA1 mRNA CTD PMID:22666520 doxorubicin decreases response to substance ISO RGD:1349200 6480464 GSTA1 protein results in decreased susceptibility to Doxorubicin CTD PMID:16890185 ebselen multiple interactions EXP 6480464 ebselen binds to and results in decreased activity of [GSTA1 protein binds to GSTA3 protein] CTD PMID:8147899 enzyme inhibitor multiple interactions EXP 6480464 Enzyme Inhibitors inhibits the reaction [Phenylpropanolamine results in increased expression of GSTA1 protein] CTD PMID:24792324 Erucin increases expression EXP 6480464 erucin results in increased expression of GSTA1 protein CTD PMID:18823965 etacrynic acid decreases response to substance ISO RGD:1349200 6480464 GSTA1 protein results in decreased susceptibility to Ethacrynic Acid CTD PMID:1985777 etacrynic acid increases expression EXP 6480464 Ethacrynic Acid results in increased expression of GSTA1 mRNA CTD PMID:9799558 etacrynic acid multiple interactions EXP 6480464 [GSTA1 protein binds to GSTA2 protein] which affects the metabolism of Ethacrynic Acid CTD PMID:9877184 etacrynic acid affects metabolic processing ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of Ethacrynic Acid analog CTD PMID:12781783 ethyl methanesulfonate increases expression ISO RGD:1349200 6480464 Ethyl Methanesulfonate results in increased expression of GSTA1 mRNA CTD PMID:23649840 eugenol decreases activity ISO RGD:1349200 6480464 Eugenol analog results in decreased activity of GSTA1 protein CTD PMID:8620581 genistein multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [Genistein results in increased expression of GSTA1 mRNA] CTD PMID:32185415 genistein increases expression EXP 6480464 Genistein results in increased expression of GSTA1 mRNA, Genistein results in increased expression of GSTA1 protein CTD PMID:32185415 , PMID:34214573 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of GSTA1 mRNA CTD PMID:33387578 glutathione multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of [Busulfan co-treated with Glutathione] more ... CTD PMID:10437668 more ... glutathione affects binding EXP 6480464 Glutathione binds to GSTA1 protein CTD PMID:10751412 glutathione multiple interactions EXP 6480464 [GSTA1 protein binds to GSTA2 protein] which affects the metabolism of Glutathione more ... CTD PMID:10496977 more ... glutathione affects metabolic processing ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of Glutathione CTD PMID:8886613 , PMID:9084911 Glutathione ethyl ester multiple interactions EXP 6480464 S-ethyl glutathione inhibits the reaction [Phenylpropanolamine results in increased expression of GSTA1 mRNA] CTD PMID:24792324 glycochenodeoxycholic acid multiple interactions EXP 6480464 Glycochenodeoxycholic Acid binds to [GSTA1 protein co-treated with GSTA1 protein], Glycochenodeoxycholic Acid binds to [GSTA3 protein co-treated with GSTA1 protein] CTD PMID:3783048 glycochenodeoxycholic acid multiple interactions ISO RGD:1349200 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTA1 mRNA more ... CTD PMID:32152650 , PMID:33819548 glycocholic acid multiple interactions ISO RGD:1349200 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTA1 mRNA more ... CTD PMID:32152650 , PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:1349200 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTA1 mRNA more ... CTD PMID:32152650 , PMID:33819548 GW 7647 increases expression EXP 6480464 GW 7647 results in increased expression of GSTA1 mRNA CTD PMID:31628012 GW 7647 decreases expression ISO RGD:1349200 6480464 GW 7647 results in decreased expression of GSTA1 mRNA CTD PMID:31628012 herbicide multiple interactions EXP 6480464 Herbicides binds to and results in decreased activity of GSTA1 protein CTD PMID:6686184 hexadecanoic acid multiple interactions ISO RGD:1349200 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of GSTA1 mRNA CTD PMID:30547786 hydrogen peroxide affects expression ISO RGD:1349200 6480464 Hydrogen Peroxide affects the expression of GSTA1 mRNA CTD PMID:20044591 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of GSTA1 mRNA CTD PMID:11008122 hypericin multiple interactions ISO RGD:1349200 6480464 hypericin binds to and results in decreased activity of GSTA1 protein CTD PMID:15461448 Idoxifene decreases expression EXP 6480464 idoxifene results in decreased expression of GSTA1 mRNA CTD PMID:9744569 iodide salt decreases expression EXP 6480464 Iodides deficiency results in decreased expression of GSTA1 protein CTD PMID:26795019 iomeprol multiple interactions EXP 6480464 [Streptozocin co-treated with iomeprol] results in increased expression of GSTA1 protein, palmidrol analog inhibits the reaction [[Streptozocin co-treated with iomeprol] results in increased expression of GSTA1 protein] CTD PMID:26474837 isomethyleugenol decreases activity ISO RGD:1349200 6480464 isomethyleugenol results in decreased activity of GSTA1 protein CTD PMID:8620581 kaempferol increases expression ISO RGD:1349200 6480464 kaempferol results in increased expression of GSTA1 mRNA CTD PMID:21256954 ketoconazole multiple interactions ISO RGD:1349200 6480464 Ketoconazole inhibits the reaction [Phenobarbital results in increased expression of GSTA1 mRNA], Ketoconazole inhibits the reaction [Rifampin results in increased expression of GSTA1 mRNA] CTD PMID:16608920 ketoconazole multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [Carbon Tetrachloride results in decreased expression of GSTA1 mRNA], Ketoconazole inhibits the reaction [Genistein results in increased expression of GSTA1 mRNA] CTD PMID:31168027 , PMID:32185415 ketoconazole decreases expression ISO RGD:1349200 6480464 Ketoconazole results in decreased expression of GSTA1 mRNA CTD PMID:16608920 KT 5720 multiple interactions ISO RGD:1349200 6480464 KT 5720 inhibits the reaction [Bucladesine results in increased expression of GSTA1 mRNA] CTD PMID:26049102 L-ascorbic acid multiple interactions ISO RGD:1349200 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mRNA, [Quercetin co-treated with Ascorbic Acid] results in decreased expression of GSTA1 mRNA CTD PMID:17639512 , PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:1349200 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mRNA CTD PMID:34480604 lauroyl-CoA multiple interactions ISO RGD:1349200 6480464 lauroyl-coenzyme A binds to and results in decreased activity of GSTA1 protein CTD PMID:10542059 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of GSTA1 protein CTD PMID:9750042 lead diacetate increases expression ISO RGD:1349200 6480464 lead acetate results in increased expression of GSTA1 mRNA CTD PMID:26498409 lead diacetate multiple interactions ISO RGD:1349200 6480464 NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GSTA1 mRNA] CTD PMID:26498409 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of GSTA1 protein CTD PMID:9750042 lead nitrate decreases expression ISO RGD:1349200 6480464 lead nitrate results in decreased expression of GSTA1 mRNA CTD PMID:31682781 lead nitrate multiple interactions ISO RGD:1349200 6480464 AHR promotes the reaction [lead nitrate results in decreased expression of GSTA1 mRNA] more ... CTD PMID:31682781 linoleic acid increases expression ISO RGD:1349200 6480464 Linoleic Acid results in increased expression of GSTA1 mRNA CTD PMID:28555106 linoleic acid multiple interactions ISO RGD:1349200 6480464 NFE2L2 protein promotes the reaction [Linoleic Acid results in increased expression of GSTA1 mRNA] CTD PMID:28555106 lithocholic acid multiple interactions ISO RGD:1349200 6480464 Lithocholic Acid binds to and results in decreased activity of GSTA1 protein CTD PMID:12206662 lithocholic acid multiple interactions EXP 6480464 Lithocholic Acid binds to [GSTA1 protein co-treated with GSTA1 protein], Lithocholic Acid binds to [GSTA3 protein co-treated with GSTA1 protein] CTD PMID:3783048 luteolin increases expression EXP 6480464 Luteolin results in increased expression of GSTA1 mRNA CTD PMID:31201582 LY294002 multiple interactions ISO RGD:1349200 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of GSTA1 mRNA] CTD PMID:15090468 mefenamic acid increases glutathionylation ISO RGD:1349200 6480464 GSTA1 protein results in increased glutathionylation of Mefenamic Acid analog CTD PMID:25372302 MeIQx decreases expression ISO RGD:1349200 6480464 2-amino-3 more ... CTD PMID:22138251 , PMID:23810796 menadione affects expression ISO RGD:1349200 6480464 Vitamin K 3 affects the expression of GSTA1 mRNA CTD PMID:20044591 mercury atom affects abundance ISO RGD:1349200 6480464 GSTA1 gene polymorphism affects the abundance of Mercury CTD PMID:19515364 mercury(0) affects abundance ISO RGD:1349200 6480464 GSTA1 gene polymorphism affects the abundance of Mercury CTD PMID:19515364 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Doxorubicin results in increased expression of GSTA1 mRNA] CTD PMID:22666520 methotrexate increases expression ISO RGD:1349200 6480464 Methotrexate results in increased expression of GSTA1 mRNA CTD PMID:24449571 methyl methacrylate increases expression ISO RGD:1349200 6480464 Methylmethacrylate results in increased expression of GSTA1 mRNA CTD PMID:19029078 microcystin RR increases glutathionylation ISO RGD:1349200 6480464 GSTA1 protein results in increased glutathionylation of microcystin RR CTD PMID:23538035 microcystin-LR multiple interactions ISO RGD:1349200 6480464 GSTA1 protein results in increased glutathionylation of and affects the susceptibility to cyanoginosin LR CTD PMID:21504230 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of GSTA1 mRNA CTD PMID:34740672 mifepristone increases expression ISO RGD:1349200 6480464 Mifepristone results in increased expression of GSTA1 mRNA CTD PMID:17584828 myristoyl-CoA multiple interactions ISO RGD:1349200 6480464 S-tetradecanoyl-coenzyme A binds to and results in decreased activity of GSTA1 protein CTD PMID:10542059 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:1349200 6480464 N more ... CTD PMID:17018880 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of GSTA1 mRNA] CTD PMID:9152014 N-acetyl-S-phenyl-L-cysteine affects abundance ISO RGD:1349200 6480464 GSTA1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine CTD PMID:20100551 N-acetyl-S-phenyl-L-cysteine multiple interactions ISO RGD:1349200 6480464 GSTA1 gene polymorphism affects the reaction [GSTM1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine] CTD PMID:20100551 N-acetylsphingosine multiple interactions ISO RGD:1349200 6480464 N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased expression of and results in increased secretion of GSTA1 protein] more ... CTD PMID:31385618 , PMID:33959992 N-hydroxy-PhIP increases expression EXP 6480464 2-hydroxyamino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of GSTA1 protein CTD PMID:17122891 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1349200 6480464 U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of GSTA1 mRNA] CTD PMID:12710931 N-nitrosodiethylamine decreases expression ISO RGD:1349200 6480464 Diethylnitrosamine results in decreased expression of GSTA1 mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTA1 protein, Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTA1 protein] CTD PMID:12725062 nefazodone multiple interactions ISO RGD:1349200 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTA1 mRNA CTD PMID:32152650 nefazodone decreases expression ISO RGD:1349200 6480464 nefazodone results in decreased expression of GSTA1 mRNA CTD PMID:32152650 nevirapine increases glutathionylation ISO RGD:1349200 6480464 GSTA1 protein results in increased glutathionylation of Nevirapine metabolite CTD PMID:27989146 nickel atom increases expression ISO RGD:1349200 6480464 Nickel results in increased expression of GSTA1 mRNA CTD PMID:14971665 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of GSTA1 mRNA CTD PMID:33484710 O-methyleugenol decreases activity ISO RGD:1349200 6480464 methyleugenol results in decreased activity of GSTA1 protein CTD PMID:8620581 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of GSTA1 mRNA CTD PMID:12700408 okadaic acid decreases expression ISO RGD:1349200 6480464 Okadaic Acid results in decreased expression of GSTA1 mRNA CTD PMID:28939011 oleic acid multiple interactions ISO RGD:1349200 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of GSTA1 mRNA CTD PMID:30547786 oleoyl-CoA multiple interactions ISO RGD:1349200 6480464 oleoyl-coenzyme A binds to and results in decreased activity of GSTA1 protein CTD PMID:10542059 oltipraz multiple interactions ISO RGD:1349200 6480464 oltipraz inhibits the reaction [Acetaminophen results in decreased expression of and results in increased secretion of GSTA1 protein] more ... CTD PMID:31385618 , PMID:33959992 oxaliplatin increases expression EXP 6480464 Oxaliplatin results in increased expression of GSTA1 mRNA CTD PMID:25729387 palmitoyl ethanolamide multiple interactions EXP 6480464 palmidrol analog inhibits the reaction [[Streptozocin co-treated with iomeprol] results in increased expression of GSTA1 protein] CTD PMID:26474837 palmitoyl-CoA multiple interactions ISO RGD:1349200 6480464 Palmitoyl Coenzyme A binds to and results in decreased activity of GSTA1 protein CTD PMID:10542059 panobinostat multiple interactions ISO RGD:1349200 6480464 [Cisplatin co-treated with panobinostat] affects the expression of GSTA1 mRNA CTD PMID:21791302 paracetamol increases expression ISO RGD:1349200 6480464 Acetaminophen results in increased expression of GSTA1 mRNA CTD PMID:26690555 paracetamol decreases expression ISO RGD:1349200 6480464 Acetaminophen results in decreased expression of GSTA1 mRNA, Acetaminophen results in decreased expression of GSTA1 protein CTD PMID:31385618 , PMID:33959992 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GSTA1 mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:1349200 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of GSTA1 mRNA more ... CTD PMID:31385618 more ... parathion-methyl multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of and results in decreased alkylation of Methyl Parathion CTD PMID:15103050 parathion-methyl increases expression ISO RGD:1349200 6480464 Methyl Parathion results in increased expression of GSTA1 mRNA, Methyl Parathion results in increased expression of GSTA1 protein CTD PMID:21907274 perfluorobutanesulfonic acid increases expression ISO RGD:1349200 6480464 perfluorobutanesulfonic acid results in increased expression of GSTA1 mRNA CTD PMID:35337807 perfluorododecanoic acid decreases expression ISO RGD:1349200 6480464 perfluorododecanoic acid results in decreased expression of GSTA1 mRNA CTD PMID:35337807 perfluorononanoic acid decreases expression ISO RGD:1349200 6480464 perfluoro-n-nonanoic acid results in decreased expression of GSTA1 mRNA CTD PMID:35337807 perfluorooctanesulfonamide increases expression ISO RGD:1349200 6480464 perfluorooctanesulfonamide analog results in increased expression of GSTA1 mRNA CTD PMID:35337807 perfluoropentanoic acid increases expression ISO RGD:1349200 6480464 perfluoropentanoic acid results in increased expression of GSTA1 mRNA CTD PMID:35337807 perfluoroundecanoic acid decreases expression ISO RGD:1349200 6480464 perfluoroundecanoic acid results in decreased expression of GSTA1 mRNA CTD PMID:35337807 phenanthrene increases expression ISO RGD:1349200 6480464 phenanthrene results in increased expression of GSTA1 mRNA CTD PMID:32890658 phenobarbital decreases expression ISO RGD:1349200 6480464 Phenobarbital results in decreased expression of GSTA1 mRNA, Phenobarbital results in decreased expression of GSTA1 protein CTD PMID:19084549 , PMID:7986210 phenobarbital multiple interactions ISO RGD:1349200 6480464 Ketoconazole inhibits the reaction [Phenobarbital results in increased expression of GSTA1 mRNA] CTD PMID:16608920 phenobarbital increases expression ISO RGD:1349200 6480464 Phenobarbital results in increased expression of GSTA1 mRNA CTD PMID:16608920 , PMID:19118567 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of GSTA1 mRNA, Phenobarbital results in increased expression of GSTA1 protein CTD PMID:10762607 more ... phenobarbital increases stability EXP 6480464 Phenobarbital results in increased stability of GSTA1 mRNA CTD PMID:10762607 phenylpropanolamine multiple interactions EXP 6480464 Enzyme Inhibitors inhibits the reaction [Phenylpropanolamine results in increased expression of GSTA1 protein] more ... CTD PMID:24792324 phenylpropanolamine increases expression EXP 6480464 Phenylpropanolamine results in increased expression of GSTA1 mRNA, Phenylpropanolamine results in increased expression of GSTA1 protein CTD PMID:24792324 phenytoin increases expression ISO RGD:1349200 6480464 Phenytoin results in increased expression of GSTA1 mRNA CTD PMID:11134551 PhIP affects response to substance ISO RGD:1349200 6480464 GSTA1 gene polymorphism affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine CTD PMID:14601045 PhIP multiple interactions ISO RGD:1349200 6480464 [xanthohumol co-treated with 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine] results in increased expression of GSTA1 mRNA CTD PMID:22138251 PhIP decreases expression ISO RGD:1349200 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of GSTA1 mRNA CTD PMID:22138251 progesterone increases chemical synthesis ISO RGD:1349200 6480464 GSTA1 protein results in increased chemical synthesis of Progesterone CTD PMID:23650189 progesterone increases expression EXP 6480464 Progesterone results in increased expression of GSTA1 mRNA CTD PMID:20726854 propiconazole affects expression EXP 6480464 propiconazole affects the expression of GSTA1 mRNA CTD PMID:17383973 prostaglandin A2 affects metabolic processing ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of prostaglandin A2 CTD PMID:9084911 prostaglandin J2 affects metabolic processing ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of 9-deoxy-delta-9-prostaglandin D2 CTD PMID:9084911 pyrazines decreases expression ISO RGD:1349200 6480464 Pyrazines results in decreased expression of GSTA1 protein CTD PMID:7986210 pyrene decreases expression ISO RGD:1349200 6480464 pyrene results in decreased expression of GSTA1 mRNA CTD PMID:32890658 quercetin multiple interactions ISO RGD:1349200 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of GSTA1 mRNA CTD PMID:17639512 quercetin increases expression EXP 6480464 Quercetin results in increased expression of GSTA1 mRNA CTD PMID:31201582 quercetin decreases expression ISO RGD:1349200 6480464 Quercetin results in decreased expression of GSTA1 mRNA CTD PMID:21632981 quercetin increases expression ISO RGD:1349200 6480464 Quercetin results in increased expression of GSTA1 mRNA CTD PMID:12756216 reactive oxygen species affects expression ISO RGD:1349200 6480464 Reactive Oxygen Species affects the expression of GSTA1 mRNA CTD PMID:25800948 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of GSTA1 mRNA CTD PMID:16169743 resveratrol multiple interactions ISO RGD:1349200 6480464 Resveratrol inhibits the reaction [lead nitrate results in decreased expression of GSTA1 mRNA] CTD PMID:31682781 rifampicin multiple interactions ISO RGD:1349200 6480464 [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of GSTA1 mRNA, Ketoconazole inhibits the reaction [Rifampin results in increased expression of GSTA1 mRNA] CTD PMID:16608920 , PMID:29162470 rifampicin increases expression ISO RGD:1349200 6480464 Rifampin results in increased expression of GSTA1 mRNA CTD PMID:16608920 , PMID:19118567 rifamycins increases expression ISO RGD:1349200 6480464 Rifamycins results in increased expression of GSTA1 protein CTD PMID:7986210 rimonabant increases expression EXP 6480464 Rimonabant results in increased expression of GSTA1 mRNA CTD PMID:30365523 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Buthionine Sulfoximine promotes the reaction [Cadmium Chloride results in increased expression of GSTA1 mRNA] CTD PMID:9152014 S-hexylglutathione affects binding ISO RGD:1349200 6480464 hexylglutathione binds to GSTA1 protein CTD PMID:12211029 , PMID:15893769 SB 431542 multiple interactions ISO RGD:1349200 6480464 [LDN 193189 co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of GSTA1 mRNA CTD PMID:34480604 Sesamol multiple interactions EXP 6480464 sesamol inhibits the reaction [Aluminum Oxide results in increased expression of GSTA1 mRNA] CTD PMID:35403826 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of GSTA1 mRNA CTD PMID:32721576 stavudine increases expression EXP 6480464 Stavudine results in increased expression of GSTA1 mRNA CTD PMID:18299183 stearoyl-CoA multiple interactions ISO RGD:1349200 6480464 stearoyl-coenzyme A binds to and results in decreased activity of GSTA1 protein CTD PMID:10542059 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with iomeprol] results in increased expression of GSTA1 protein, palmidrol analog inhibits the reaction [[Streptozocin co-treated with iomeprol] results in increased expression of GSTA1 protein] CTD PMID:26474837 sulfluramid increases expression ISO RGD:1349200 6480464 sulfluramid results in increased expression of GSTA1 mRNA CTD PMID:35337807 sulforaphane multiple interactions ISO RGD:1349200 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of GSTA1 mRNA], SN50 peptide inhibits the reaction [sulforaphane results in increased expression of GSTA1 mRNA] CTD PMID:15090468 sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of GSTA1 mRNA, sulforaphane results in increased expression of GSTA1 protein CTD PMID:11264000 , PMID:18823965 sulforaphane increases expression ISO RGD:1349200 6480464 sulforaphane results in increased expression of GSTA1 mRNA CTD PMID:12151360 more ... sulforaphane decreases expression ISO RGD:1349200 6480464 sulforaphane results in decreased expression of GSTA1 mRNA CTD PMID:12949046 sunitinib increases expression ISO RGD:1349200 150537096 Sunitinib increases expression of GSTA1 mRNA in breast epithelium RGD sunitinib affects expression EXP 6480464 sunitinib affects the expression of GSTA1 mRNA CTD PMID:26797788 Sunset Yellow FCF multiple interactions ISO RGD:1349200 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of GSTA1 mRNA CTD PMID:33819548 tamoxifen decreases activity EXP 6480464 Tamoxifen results in decreased activity of GSTA1 protein CTD PMID:8706011 tamoxifen decreases expression EXP 6480464 Tamoxifen metabolite results in decreased expression of GSTA1 mRNA more ... CTD PMID:8706011 , PMID:9744569 tartrazine multiple interactions ISO RGD:1349200 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA1 mRNA CTD PMID:33819548 tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of GSTA1 protein CTD PMID:24090815 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTA1 protein more ... CTD PMID:12725062 , PMID:31168027 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GSTA1 mRNA CTD PMID:31150632 , PMID:31168027 tetrahydrothiophene increases chemical synthesis ISO RGD:1349200 6480464 GSTA1 protein results in increased chemical synthesis of tetrahydrothiophene CTD PMID:12429583 tetraphene decreases expression ISO RGD:1349200 6480464 benz(a)anthracene results in decreased expression of GSTA1 mRNA CTD PMID:32890658 thioacetamide multiple interactions EXP 6480464 Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in decreased expression of GSTA1 protein] CTD PMID:12370186 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GSTA1 mRNA CTD PMID:15497818 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of GSTA1 mRNA, Thioacetamide results in decreased expression of GSTA1 protein CTD PMID:12370186 , PMID:34492290 Thiotepa multiple interactions ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of [Thiotepa co-treated with Glutathione] CTD PMID:7712478 Thiotepa affects response to substance ISO RGD:1349200 6480464 GSTA1 protein affects the susceptibility to Thiotepa CTD PMID:19076156 Thiotepa affects export ISO RGD:1349200 6480464 GSTA1 gene SNP affects the export of Thiotepa CTD PMID:19076156 topotecan increases expression EXP 6480464 Topotecan results in increased expression of GSTA1 mRNA CTD PMID:25729387 toremifene decreases expression EXP 6480464 Toremifene results in decreased expression of GSTA1 mRNA CTD PMID:9744569 triadimefon affects expression EXP 6480464 triadimefon affects the expression of GSTA1 mRNA CTD PMID:17383973 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of GSTA1 mRNA CTD PMID:33387578 triclosan multiple interactions ISO RGD:1349200 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of GSTA1 mRNA CTD PMID:33819548 Tris(1-aziridinyl)phosphine oxide affects export ISO RGD:1349200 6480464 GSTA1 gene SNP affects the export of Triethylenephosphoramide CTD PMID:19076156 Tris(1-aziridinyl)phosphine oxide affects response to substance ISO RGD:1349200 6480464 GSTA1 protein affects the susceptibility to Triethylenephosphoramide CTD PMID:19076156 Tris(2,3-dibromopropyl) phosphate affects metabolic processing ISO RGD:1349200 6480464 GSTA1 protein affects the metabolism of tris(2, 3-dibromopropyl)phosphate CTD PMID:8242859 Tris(2,3-dibromopropyl) phosphate increases response to substance ISO RGD:1349200 6480464 GSTA1 protein results in increased susceptibility to tris(2, 3-dibromopropyl)phosphate CTD PMID:8242859 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1349200 6480464 tris(2-butoxyethyl) phosphate affects the expression of GSTA1 mRNA CTD PMID:29024780 urethane decreases expression ISO RGD:1349200 6480464 Urethane results in decreased expression of GSTA1 mRNA CTD PMID:28818685 usnic acid increases expression ISO RGD:1349200 6480464 usnic acid results in increased expression of GSTA1 protein CTD PMID:27369375 valproic acid decreases expression ISO RGD:1349200 6480464 Valproic Acid results in decreased expression of GSTA1 mRNA CTD PMID:23179753 , PMID:28001369 xanthohumol decreases expression ISO RGD:1349200 6480464 xanthohumol results in decreased expression of GSTA1 mRNA CTD PMID:22138251 xanthohumol multiple interactions ISO RGD:1349200 6480464 [xanthohumol co-treated with 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine] results in increased expression of GSTA1 mRNA CTD PMID:22138251 XAV939 multiple interactions ISO RGD:1349200 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mRNA CTD PMID:34480604
